Published in Appl Clin Inform on November 23, 2016
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
A randomized trial of genotype-guided dosing of warfarin. N Engl J Med (2013) 7.18
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
National surveillance of emergency department visits for outpatient adverse drug events. JAMA (2006) 6.24
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation (2007) 5.99
Cognitive and usability engineering methods for the evaluation of clinical information systems. J Biomed Inform (2004) 5.13
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther (2012) 4.05
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther (2012) 3.15
Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup. J Am Med Inform Assoc (2005) 3.10
Evaluating informatics applications--clinical decision support systems literature review. Int J Med Inform (2001) 3.02
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
STARE-HI--Statement on reporting of evaluation studies in Health Informatics. Int J Med Inform (2008) 1.94
Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm (2011) 1.85
Interface design principles for usable decision support: a targeted review of best practices for clinical prescribing interventions. J Biomed Inform (2012) 1.73
Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C Semin Med Genet (2014) 1.57
Pharmacogenetics: from bench to byte. Clin Pharmacol Ther (2008) 1.40
The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther (2013) 1.37
The role of standardized data and terminological systems in computerized clinical decision support systems: literature review and survey. Int J Med Inform (2010) 1.32
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program. Am J Med Genet C Semin Med Genet (2014) 1.19
The IGNITE network: a model for genomic medicine implementation and research. BMC Med Genomics (2016) 1.17
Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics (2013) 1.14
Feasibility of implementing a comprehensive warfarin pharmacogenetics service. Pharmacotherapy (2013) 1.09
Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach. Int J Med Inform (2014) 1.03
Prerequisites to implementing a pharmacogenomics program in a large health-care system. Clin Pharmacol Ther (2014) 0.95
Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. J Thromb Thrombolysis (2010) 0.92
Design and implementation of a hospital-based usability laboratory: insights from a Department of Veterans Affairs laboratory for health information technology. Jt Comm J Qual Patient Saf (2012) 0.90
Cognitive analysis of a medication reconciliation tool: applying laboratory and naturalistic approaches to system evaluation. Stud Health Technol Inform (2011) 0.86
Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services. Pharmacotherapy (2016) 0.84
Translation of pharmacogenetics into clinically relevant testing modalities. Clin Pharmacol Ther (2007) 0.81
Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration - experience from a pediatric tertiary care facility. J Am Med Inform Assoc (2016) 0.80
Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts. Int J Med Inform (2015) 0.77
Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges. Clin Transl Sci (2016) 0.77
Experiential training for pharmacy students: time for a new approach. Can J Hosp Pharm (2012) 2.20
Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy (2004) 1.71
Effect of drugs on defibrillation capacity. Drugs (2008) 1.58
The net fiscal impact of a chronic disease management program: Indiana Medicaid. Health Aff (Millwood) (2008) 1.48
Exploring the persistence of paper with the electronic health record. Int J Med Inform (2009) 1.41
How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich) (2003) 1.34
Lessons learned from usability testing of the VA's personal health record. J Am Med Inform Assoc (2011) 1.34
Paper persistence, workarounds, and communication breakdowns in computerized consultation management. Int J Med Inform (2011) 1.21
Paper- and computer-based workarounds to electronic health record use at three benchmark institutions. J Am Med Inform Assoc (2013) 1.17
A human factors investigation of medication alerts: barriers to prescriber decision-making and clinical workflow. AMIA Annu Symp Proc (2009) 1.16
Prescribers' interactions with medication alerts at the point of prescribing: A multi-method, in situ investigation of the human-computer interaction. Int J Med Inform (2012) 1.12
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin (2013) 1.09
Evaluation of an online tobacco cessation course for health professions students. Am J Pharm Educ (2010) 1.08
Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current in a perfused heart model. Pharmacotherapy (2008) 1.07
The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg (2011) 1.05
Telephonic case-finding of major depression in a Medicaid chronic disease management program for diabetes and heart failure. Gen Hosp Psychiatry (2005) 1.04
You and me and the computer makes three: variations in exam room use of the electronic health record. J Am Med Inform Assoc (2013) 1.04
Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm (2010) 1.02
Drug-induced atrial fibrillation. Drugs (2012) 1.01
Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy (2003) 0.96
The Indiana Chronic Disease Management Program's impact on medicaid claims: a longitudinal, statewide evaluation. Med Care (2009) 0.90
Association between preference-based health-related quality of life and asthma severity. Ann Allergy Asthma Immunol (2004) 0.88
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy (2007) 0.85
Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Am J Kidney Dis (2005) 0.85
Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans. Pharmacotherapy (2011) 0.85
Medication therapy management survey of the prescription drug plans. J Am Pharm Assoc (2003) (2006) 0.83
When 'technically preventable' alerts occur, the design--not the prescriber--has failed. J Am Med Inform Assoc (2012) 0.83
Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program. Pharmacotherapy (2014) 0.81
Implementation of inpatient and outpatient tobacco-cessation programs. Am J Health Syst Pharm (2007) 0.81
Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors. Clin Pharmacol Ther (2004) 0.80
High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis. Antimicrob Agents Chemother (2012) 0.79
Pharmaceutical care services for patients with hypertension. Ann Pharmacother (2003) 0.78
Effectiveness of a pharmacy care management program for veterans with dyslipidemia. Pharmacotherapy (2013) 0.78
Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy (2006) 0.77
Influence of i.v. haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs. Chest (2004) 0.77
The structure and content of telephonic scripts found useful in a Medicaid Chronic Disease Management Program. Chronic Illn (2010) 0.76
Recruitment of community pharmacies in a randomized trial to generate patient referrals to the tobacco quitline. Res Social Adm Pharm (2012) 0.76
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments. Am J Kidney Dis (2013) 0.75
The need for a broader view of human factors in the surgical domain. Arch Surg (2011) 0.75
Role of the pharmacist in managing hypertension in patients with diabetes. Am J Health Syst Pharm (2006) 0.75
Medication Use among Veterans across Health Care Systems. Appl Clin Inform (2017) 0.75
Bleeding associated with eptifibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors. J Clin Pharmacol (2002) 0.75
Pharmacists' experiences with a telephonic medication therapy management program for home health care patients. Consult Pharm (2015) 0.75
Participant satisfaction with a community-based medication synchronization program. J Am Pharm Assoc (2003) (2015) 0.75
Home-Based Comprehensive Medication Reviews: Pharmacist's Impact on Drug Therapy Problems in Geriatric Patients. Consult Pharm (2016) 0.75
APhA2009 House of Delegates: serving the association and the profession. J Am Pharm Assoc (2003) (2009) 0.75
Outcomes of American Lung Association-Indiana Lung Centers asthma program. Dis Manag (2005) 0.75
Paroxysmal beta-adrenergic receptor-mediated alterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents. J Cardiovasc Pharmacol (2009) 0.75
Crossing the Communication Chasm: Challenges and Opportunities in Transitions of Care from the Hospital to the Primary Care Clinic. Jt Comm J Qual Patient Saf (2016) 0.75
A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency. Jt Comm J Qual Patient Saf (2015) 0.75
Comprehensive medication review recipients' opinions, actions, and information recall. J Am Pharm Assoc (2003) (2017) 0.75
Adapting Cognitive Task Analysis to Investigate Clinical Decision Making and Medication Safety Incidents. J Patient Saf (2017) 0.75